[1
]
From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.)
and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne,
Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences
(F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery
Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T.,
S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash University, Melbourne,
Australia; Department of Pathology, University of Melbourne, Australia (A.E.-O.);
and Institute the Heart Centre, Alfred Hospital, Melbourne, Australia (D.M.K.). david.kaye@baker.edu.au
francine.marques@baker.edu.au.
[2
]
From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.)
and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne,
Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences
(F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery
Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T.,
S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash University, Melbourne,
Australia; Department of Pathology, University of Melbourne, Australia (A.E.-O.);
and Institute the Heart Centre, Alfred Hospital, Melbourne, Australia (D.M.K.).